Cuprimine (penicillamine) was made available in the Philippines by the Sponsor under a Compassionate Special Permit issued by the Bureau of Food and Drugs. Physicians were able to request the drug for their patients from the Sponsor. A Clinical Study Report form was completed for each purchase of Cuprimine.
Study Type
EXPANDED_ACCESS
Dosage determined by the physician based on indication for treatment
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.